The Nordic countries' national registries allow for the creation of large cohort studies that are impossible in most other countries. This is realizable due to the existence of a wide range of government-maintained nationwide public registries, containing individual-level data collected routinely for administrative purposes that touch on most facets of our lives, including health. These registries can be linked through a common key, the unique personal identification number assigned to all residents in the Nordic countries since the establishment of national civil registry systems between 1964-1969 [1] . The personal identification number makes it possible to link individual-level data from different registries, allowing for a lifelong follow-up time. Although linking and analysing such data in many countries would be considered infringement on rights to privacy and personal ownership of data, the Nordic region is characterized by high levels of trust towards public institutions [2] , manifest in a general public expectation, encoded in law, that information gathered administratively is used to produce new knowledge of social value [3] . This makes it possible to analyse an entire country as an open cohort, censored only by death and emigration [4] . Often compared to a gold mine, the atmosphere surrounding the use of this data certainly compares to that of a gold rush. Quoting Schmidt et al., 'the possibility of exact individual-level data linkage provides unlimited possibilities for epidemiological research' [5] . Indeed, the major advantages created by this data for epidemiological and other types of research in the Nordic countries has already proved itself and there is no reason to dismiss the promises held by this research to benefit public health worldwide.
At the same time, the complex and varied processes of data collection, processing and quality controls underpinning registry data calls for detailed attention to their validity and completeness. As shifting administrative procedures and priorities can have large impacts on the data we analyse, the interpretation of our findings hinges on our familiarity with the details of data production. In addition, registry data are not immune to errors and misclassification and validation studies of specific registries are crucial to assess the accuracy of information. Being awake to the possibilities of registry data, a stable feature of the conversation within our research community must be to delve deeper into these issues.
In appreciation of the unique potential of these data for epidemiological research in the Nordic countries, the first three issues of 2020 of the Scandinavian Journal of Public Health are dedicated to registry data. The much-cited 2011 special issue of Scandinavian Journal of Public Health introduced and discussed a broad array of Danish registries and has become an important asset for researchers analyzing registry data. From the editorial board, we felt it was timely for another round of special issues dedicated to registry data. This specific issue (Part I of the three special issues) has two main themes. The first is to add presentations of Nordic registries as well as new validity studies that expand our understanding of the Nordic registries. We have attempted to include articles covering the Nordic region broadly. The second is to explore further the potentials of these data, providing examples of both how registry data can be used to include population groups that are hard to reach or otherwise not singled out in quantitative research as well as registry data in combination with other types of data.
In this issue of Scandinavian Journal of Public Health, six studies specifically address the validity and completeness of particular registries. Validity is usefully thought of in terms of the positive predicted value, the number of true cases in the registry divided by the total number of cases in the registry, whereas completeness can be thought of in terms of sensitivity, the number of true cases in the registry divided by the actual number of true cases [6] . Both the methods employed and the findings are instructive for registrybased research. In particular, when the registries are often hailed as a gold standard in themselves, by which standard can they be judged? The included studies approach this challenge from different angles. Three studies, govatsmark et al., Kirkegård et al. and Vuori et al., developed a gold standard based on a careful review of electric health records. For example, to investigate the completeness and correctness of the acute myocardial infarction diagnoses, govatsmark and colleagues reviewed the electronic health records for all hospitalizations during a particular period at a particular Norwegian hospital with maximum troponin T values higher than 10 ng/l, thereby establishing a uniformly identified list of true cases of myocardial infarction. Cases identified in the Norwegian myocardial Infarction register and the Norwegian Patient register were then compared with this list to calculate sensitivity, specificity, positive predicted values (PPV) and negative predicted values. The findings suggest both registries in fact exhibit high levels of completeness (assessed as the sensitivity) and validity (assessed as the PPV). At the same time, 14% of true cases were found not to be present in the registries. The authors discuss how both typing errors and changing diagnostic criteria played a part in this. Awareness of such issues equips researchers to critically reflect on their data.
Another two studies, Fugelstad et al. and Kleif et al., relied on another dataset containing cases plausibly true. An example of this is Fugelstad and colleagues, who use a complete inventory of drug-related deaths in the Stockholm area, in which each case had been individually assessed, to measure up against the National mortality register and the Swedish Toxreg register based on forensic toxicology results. In addition to considering the validity and completeness of each of these registries, the authors analyse whether they capture and miss the same kinds of deaths. Although most of the validation studies included in this issue conclude that the examined registries are highly reliable, the findings of Fugelstad and colleagues are sobering. One-third of cases in the inventory are not in the mortality registry and one-quarter are missing in the Toxreg register. In addition, although the two registries have similar numbers of deaths, large numbers of cases in one of the registries are missing in the other. This is in part because the national mortality registry lacks the precision necessary to identify drug related deaths, whereas the forensic toxicology statistics lack information on deaths not related to acute intake, such as gradual drug-related organ damage. These findings have important consequences for how results using the registries are used in international comparisons and for monitoring the current drug situation in the country. The central strength of the national mortality registry is that it is coded similarly across countries, whereas the more detailed information in the Toxreg register gives better opportunities for assessing changes in the actual drug situation.
Finally, Jensen and colleagues explore the validity of the electronic Patient medication research module for in-hospital drug use in the Capital region in Denmark by assessing how the records accord with the clinical version of the database, but also through observations of real-life practices of registrations at three different hospital units. This approach usefully anchors our considerations of sources of error within the registry on the registration practices it relies on. In discussing their findings, they highlight how external factors such as the time of day, how busy the unit is and whether it is an emergency setting may all influence the quality of registrations. That said, the near-perfect accordance they report does underscore the research potential of this registry.
In addition to these validation studies, two further studies provide new descriptions of health registries of great use for researchers seeking to understand the information available in these. From Norway, Bakken and colleagues describe the contents and data-collection processes of the Norwegian Patient registry and the Norwegian registry for Primary Health Care. They also review more than 200 studies making use of these data and provide examples that highlight their potential. From Sweden, löfvendahl and colleagues introduce the Skåne Healthcare register (SHr). The SHr contains information on contacts in primary care, secondary outpatient care as well as tertiary care at hospitals, and especially since 2004 most contacts include diagnostic information. They also review literature using SHr published between 2000 and 2018 to illustrate the use and potential of this registry.
Some population groups are hard to reach for researchers for various reasons, including language issues, mental illness, overall physical and mental health condition, abusive behaviour and dementia. These groups' health issues might therefore be under-appreciated in quantitative research. This issue on Nordic registry Data provides several examples of how the registries make it possible to include groups that may otherwise be missed. In the article on antipsychotic medication use in the largest immigrant groups in Finland, Bosqui and colleagues argue the level of access to and use of psychiatric treatment among immigrants has been studied insufficiently despite the fact that a higher incidence of psychotic disorders for immigrants compared to native-born has consistently been found. By linking psychotropic drug prescription purchases in Finland as a proxy for access to and use of mental health services with socio-economic characteristics, including country of birth, the authors are able to study an otherwise overpassed and vulnerable group. This particular group is in great need of healthcare services and the results may help inform initiatives to strengthen mental health service access for immigrants with psychotic, or related, conditions. likewise, recruiting persons aged >70 years in quantitative health research might be challenging. lindéus and colleagues studied health inequalities in mortality from hip and non-hip fractures in Sweden's Skåne region using registrydata linkage. The findings indicate that preventative and therapeutic interventions for fractures should pay special attention to elderly people with low-level education. Another example of the inclusion of hardto-reach groups is the article of Konnto and colleagues studying the profile of non-respondents in the Finnish gambling 2015 survey.
The large size of most registry-based studies also makes it possible to disaggregate findings more precisely than is often possible using other methods. This means some population groups may not be singled out in quantitative research despite a theoretically sound rationale for doing so. For instance, although novel research often demonstrates great health and health-related differences between immigrants and their descendants, many studies are not able to distinguish between immigrants over generations. Thus, immigrants and their descendants have often been pooled into one group or descendants have simply been left out of the analyses. In this issue, using Finnish registry data, Heino and colleagues are able to differentiate between immigrants and their descendants in induced abortion rates and contraceptive use, which show major differences across generations. These refined analyses nuance our understanding of how practices related to reproductive health develop over generations within families with a recent migration history.
The issue also contains examples of studies that fruitfully combine registry data with other types of information to bring new knowledge or new perspectives to the findings produced using either. The article by Pedersen et al. on how children who are delayed in the childhood vaccination program are vaccinated makes use of a combination of registry data and semi-structured interviews. This allows the authors not only to examine compliance with the guidelines for the administration of delayed vaccination, but also to understand the reasons for noncompliance with the vaccination guidelines among vaccination providers who are identified through the registries. Another example is the study by Jørgensen et al. who aimed to provide up-to-date information on undiagnosed type 2 diabetes and pre-diabetes based on current diagnostic criteria. The authors applied information on known, undiagnosed and pre-diabetes prevalence from a large survey along with assessments of the survey participation rate to the entire Danish population to estimate the number with undiagnosed type 2 diabetes and pre-diabetes. Konnto and colleagues aimed to define the profile of non-respondents in the Finnish gambling 2015 survey and used registry-based information to build a non-respondent profile for the survey. The authors conclude that socio-economic position was associated with lower response rate in the Finnish gambling survey, which may cause bias when studying gambling behaviour of socio-economically disadvantaged individuals. Thereby, these studies illustrate other and new potentials of registry data, including how the combination of registry data with different information sources can further our understanding.
In the short communication on patient and public involvement on research in this issue, Sand and colleagues highlight that the main reasons for involving patients and other citizens in health research are to enhance the quality and relevance of research and that doing so conforms with widely held democratic principles in these societies. In registry-based research, patient and public involvement is likewise relevant. Alriksson-Schmidt and colleagues argue on this very topic that research needs to be relevant and appropriate to the users (for example, patients and healthcare providers) as well as to have the potential to benefit the users. One way to accommodate this is to established user boards with patients, the community and policymakers to serve as research advisors and research communicators as suggested by Alriksson-Schmidt et al.
Despite the rich and valuable registry data in the single Nordic countries, obstacles concerning wellpowered samples are still present in studies of rare diseases or infrequent events by population subgroups to conduct robust studies with a high degree of external validity. To fully realize the potential of Nordic registry data, the possibilities for integrating data from several countries need to be explored further. Alriksson-Schmidt and colleagues' article in this issue makes an important contribution in this regard, as they present their early experiences of merging national registries and follow-up programmes on cerebral palsy, an uncommon condition,
